Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Nonalcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05041673
What this trial is testing

Anti-diabetic Drugs and Fatty Liver Management

Who this might be right for
Fatty Liver, NonalcoholicDiabetes Mellitus, Type 2
Alexandria University 120
Testing effectiveness (Phase 2)Study completedNCT02279524
What this trial is testing

A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH

Who this might be right for
Fatty LiverNon-Alcoholic SteatohepatitisLiver Diseases+1 more
Galmed Research and Development, Ltd. 247
Testing effectiveness (Phase 2)Study completedNCT03656068
What this trial is testing

An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis

Who this might be right for
Non-alcoholic SteatohepatitisFatty LiverFibrosis, Liver+1 more
Pinnacle Clinical Research, PLLC 21
Testing effectiveness (Phase 2)Ended earlyNCT03868566
What this trial is testing

An Open-Label Study to Assess the Hepatic Protection Effect of SNP-612, in Patients With NAFLD

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Sinew Pharma Inc. 90
Post-approval studies (Phase 4)WithdrawnNCT01269320
What this trial is testing

Natural Soybean-derived Femarelle ®for Patients With Non Alcoholic Fatty Liver Disease

Who this might be right for
Nash
Hadassah Medical Organization
Post-approval studies (Phase 4)UnknownNCT03950505
What this trial is testing

To Evaluate the Effect of Nesinaact on Non-alcoholic Steatohepatitis Through MRI and Liver Fibroscan in Patients With Type 2 Diabetes

Who this might be right for
Non-alcoholic SteatohepatitisType2 Diabetes
Yonsei University 60
Not applicableStudy completedNCT05792488
What this trial is testing

Lifestyle Guidance Methods in NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Ziekenhuis Oost-Limburg 300
Testing effectiveness (Phase 2)Ended earlyNCT05282121
What this trial is testing

Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Who this might be right for
Liver DiseasesHypertension, Portal
Boehringer Ingelheim 90
Testing effectiveness (Phase 2)Ended earlyNCT00529204
What this trial is testing

Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease

Who this might be right for
Diabetes ComplicationsFatty Liver
University of California, Davis 1
Not applicableStudy completedNCT05092399
What this trial is testing

Effects of VLCD and Bariatric Surgery in Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesNAFLDObesity
University of Nottingham 21
Not applicableUnknownNCT03377153
What this trial is testing

The Effects of Hesperidin and Flaxseed on Biochemical Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Steatohepatitis
National Nutrition and Food Technology Institute 50
Not applicableStudy completedNCT05579158
What this trial is testing

Effects of Time-restricted Eating Supported by Mobile Technology in Patients With Non-alcoholic Fatty Liver Disease: Randomized Controlled Trial

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseTime Restricted FeedingMobile Technology
Hanyang University 337
Large-scale testing (Phase 3)Study completedNCT05768334
What this trial is testing

Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLD
Helwan University 116
Not applicableNot Yet RecruitingNCT07740109
What this trial is testing

The Effects of 5-methyltetrahydrofolate Supplementation in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease (NAFLD)MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+7 more
Tabriz University of Medical Sciences 44
Not applicableEnded earlyNCT03866421
What this trial is testing

NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseChronic Kidney DiseasesPreDiabetes+1 more
Rigshospitalet, Denmark 3
Not applicableStudy completedNCT05485714
What this trial is testing

Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced Fibrosis

Who this might be right for
Esophageal VaricesNon-alcoholic Fatty LiverCompensated Cirrhosis
United Arab Emirates University 73
Not applicableUnknownNCT01694342
What this trial is testing

Telomere Parameters in Patients With Nonalcoholic Fatty Liver

Who this might be right for
FATTY LIVERNO MALIGNANCYNO DECOMPENSATED ILLNESS
Meir Medical Center 30
Not applicableStudy completedNCT05378321
What this trial is testing

Prevalence of NAFLD in ACS Patients

Who this might be right for
NAFLDACS - Acute Coronary Syndrome
Ziekenhuis Oost-Limburg 225
Post-approval studies (Phase 4)UnknownNCT01950884
What this trial is testing

Lifestyle Versus Ezetimibe Plus Lifestyle in Patients With Non-alcoholic Steatohepatitis

Who this might be right for
•Non-alcoholic Steatohepatitis (NASH)
University of Palermo 45
Large-scale testing (Phase 3)UnknownNCT04756544
What this trial is testing

The Influence of Probiotic Supplementation on Depressive Symptoms, Inflammation and Oxidative Stress Parameters and Faecal Microbiota in Patients With Depression Depending on Metabolic Syndrome Comorbidity

Who this might be right for
Depressive DisorderDepressionAnxiety+3 more
Medical University of Lodz 200
Next Page